共 71 条
- [31] Gibaldi M., Bioequivalence of thyroid preparations: The final word?, American Association of Pharmaceutical Scientists, 7, (2005)
- [32] Gnant M.F., Mlineritsch B., Luschin-Ebengreuth G., Grampp S., Kaessmann H., Schmid M., Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: A report from the Austrian Breast and Colorectal Cancer Study Group, Journal of Clinical Oncology, 25, pp. 820-828, (2007)
- [33] Goodwin P., Vitamin D in Cancer Patients: Above All, Do No Harm, (2009)
- [34] Grundy S., Obesity, metabolic syndrome, and cardiovascular disease, Journal of Clinical Endocrinology and Metabolism, 89, pp. 2595-2600, (2004)
- [35] Hewitt M., Greenfield S., Stovall E., From Cancer Patient to Cancer Survivor: Lost in Transition, (2006)
- [36] Hewitt M., Rowland J., Yancik R., Cancer survivors in the United States: Age, health, and disability, Journal of Gerontology, 58, pp. 82-91, (2003)
- [37] Hu F.B., Manson J.E., Liu S., Hunter D., Colditz G.A., Michels K.B., Giovannucci E., Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women, Journal of the National Cancer Institute, 91, pp. 542-547, (1999)
- [38] Izzedine H., Ederhy S., Goldwasser F., Soria J.C., Milano G., Cohen A., Spano J.P., Management of hypertension in angiogenesis inhibitor-treated patients, Annals of Oncology, 20, pp. 807-815, (2009)
- [39] Jain M., Townsend R., Chemotherapy agents and hypertension: A focus on angiogenesis blockage, Current Hypertension Reports, 9, pp. 320-328, (2007)
- [40] Katzung B.G., Basic and Clinical Pharmacology, (2004)